These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Glandular and extraglandular expression of the Fas-Fas ligand and apoptosis in patients with Sjögren's syndrome. Matsumura R, Umemiya K, Kagami M, Tomioka H, Tanabe E, Sugiyama T, Sueishi M, Nakajima A, Azuma M, Okumura K, Sumida T. Clin Exp Rheumatol; 1998; 16(5):561-8. PubMed ID: 9779303 [Abstract] [Full Text] [Related]
7. Aquaporins in secretory glands and their role in Sjögren's syndrome. Delporte C. Handb Exp Pharmacol; 2009; (190):185-201. PubMed ID: 19096778 [Abstract] [Full Text] [Related]
8. Fas and Fas-mediated effects on a human salivary cell line in vitro: a model for immune-mediated exocrine damage in Sjögren's syndrome. Gannot G, Bermudez D, Lillibridge D, Fox PC. Cell Death Differ; 1998 Sep; 5(9):743-50. PubMed ID: 10200533 [Abstract] [Full Text] [Related]
9. The salivary gland epithelial cell in Sjogren's Syndrome: what are the steps involved in wounding or killing their secretory function? Fox RI. J Rheumatol; 2012 Jun; 39(6):1117-9. PubMed ID: 22661415 [No Abstract] [Full Text] [Related]
10. Mikulicz's disease and Sjögren's syndrome. Tsubota K, Fujita H, Tsuzaka K, Takeuchi T. Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1666-73. PubMed ID: 10845583 [Abstract] [Full Text] [Related]
11. [Effect of nourishing Yin, strengthening Qi and activating blood decoction on Fas/FasL in salivary glands of NOD mice with Sjogren's syndrome and their mRNA expression]. Wu GL, Li TY, Lu WW, Yu GY, Fan YS. Zhongguo Zhong Yao Za Zhi; 2013 Dec; 38(23):4148-51. PubMed ID: 24791507 [Abstract] [Full Text] [Related]
12. Improvement of lacrimal function by topical application of CyA in murine models of Sjögren's syndrome. Tsubota K, Fujita H, Tadano K, Takeuchi T, Murakami T, Saito I, Hayashi Y. Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):101-10. PubMed ID: 11133854 [Abstract] [Full Text] [Related]
13. The role of caspase cascade on the development of primary Sjögren's syndrome. Hayashi Y, Arakaki R, Ishimaru N. J Med Invest; 2003 Feb; 50(1-2):32-8. PubMed ID: 12630566 [Abstract] [Full Text] [Related]
15. Male NOD mouse external lacrimal glands exhibit profound changes in the exocytotic pathway early in postnatal development. da Costa SR, Wu K, Veigh MM, Pidgeon M, Ding C, Schechter JE, Hamm-Alvarez SF. Exp Eye Res; 2006 Jan; 82(1):33-45. PubMed ID: 16005870 [Abstract] [Full Text] [Related]
16. Quantitative analysis of lacrimal gland function, apoptotic figures, Fas and Fas ligand expression of lacrimal glands in dry eye patients. Tsubota K, Fujita H, Tsuzaka K, Takeuchi T. Exp Eye Res; 2003 Feb; 76(2):233-40. PubMed ID: 12565811 [Abstract] [Full Text] [Related]
17. Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome. Meng Z, Klinngam W, Edman MC, Hamm-Alvarez SF. PLoS One; 2017 Feb; 12(9):e0184781. PubMed ID: 28902875 [Abstract] [Full Text] [Related]
18. [Study of apoptosis in Sjögren's syndrome]. Ogawa N, Ohashi H. Rinsho Byori; 1997 Jul; 45(7):643-8. PubMed ID: 9256010 [Abstract] [Full Text] [Related]
19. Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren's Syndrome. Soyfoo MS, Chivasso C, Perret J, Delporte C. Int J Mol Sci; 2018 Oct 30; 19(11):. PubMed ID: 30380700 [Abstract] [Full Text] [Related]
20. CD4 mononuclear cell infiltrates and Fas/Fas ligand positive mammary gland cells in breast tissue from a patient with Sjögren's syndrome. Attias MR, Kong L, Tortolero M, Maccarone BG, Nakabayashi T, Talal N, Dang H. J Rheumatol; 1998 Jun 30; 25(6):1226-31. PubMed ID: 9632092 [Abstract] [Full Text] [Related] Page: [Next] [New Search]